Jirui Sun

Key Laboratory Of Molecular Pathology And Early Diagnosis Of Tumor In Hebei Province
Baoding, 071000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Neoadjuvant pyrotinib for HER2 (IHC 2+/FISH+)/HR+ breast cancer with early non-response: a case report and literature review.

Neoadjuvant pyrotinib for HER2 (IHC 2+/FISH+)/HR+ breast cancer with early non-response: a case report and literature review.

Journal: Frontiers in medicine

Published: February 06, 2026

Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma.

Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma.

Journal: Discover oncology

Published: May 22, 2025

Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells.

Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells.

Journal: Science advances

Published: January 10, 2025

Pan-cancer characterization of C-C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target.

Pan-cancer characterization of C-C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target.

Journal: Discover oncology

Published: July 14, 2024

Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis.

Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: February 13, 2024

Peimenine unleashes therapeutic promise in urothelial bladder cancer: inhibition of proliferation, induction of cell death and modulation of key pathways.

Peimenine unleashes therapeutic promise in urothelial bladder cancer: inhibition of proliferation, induction of cell death and modulation of key pathways.

Journal: Chemical biology & drug design

Published: November 24, 2023

Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation.

Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation.

Journal: Frontiers in oncology

Published: March 07, 2023

A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma.

A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma.

Journal: Journal of cellular and molecular medicine

Published: February 04, 2023

Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer.

Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer.

Journal: Journal of nanobiotechnology

Published: January 24, 2023

c-Jun-mediated JMJD6 restoration enhances resistance of liver cancer to radiotherapy through the IL-4-activated ERK pathway.

c-Jun-mediated JMJD6 restoration enhances resistance of liver cancer to radiotherapy through the IL-4-activated ERK pathway.

Journal: Cell biology international

Published: November 10, 2022

Recent Development and Future Prospects of Molecular Targeted Therapy in Prostate Cancer.

Recent Development and Future Prospects of Molecular Targeted Therapy in Prostate Cancer.

Journal: Current molecular pharmacology

Published: January 12, 2021

Betulin ameliorates 7,12-dimethylbenz(a)anthracene-induced rat mammary cancer by modulating MAPK and AhR/Nrf-2 signaling pathway.

Betulin ameliorates 7,12-dimethylbenz(a)anthracene-induced rat mammary cancer by modulating MAPK and AhR/Nrf-2 signaling pathway.

Journal: Journal of biochemical and molecular toxicology

Published: October 14, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026